Evidence map›Paper›PMID 32372997›Full record

ArticleFrontiers in psychology2020

Development and Preliminary Validation of a New Type 1 Diabetes Adjustment Scale (DAS-1).

Teresa Rivas, Mónica Carreira, Marta Domínguez-López, Maria Soledad Ruiz de Adana, María Teresa Anarte

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Teresa RivasDepartment of Psychobiology and Behavioral Sciences Methodology, University of Málaga, Málaga, Spain.
Mónica CarreiraDepartment of Personality, Assessment and Psychological Treatment, Institute of Biomedical Research of Malaga (IBIMA), University of Málaga, Málaga, Spain.
Marta Domínguez-LópezDiabetes Unit, Department of Endocrinology and Nutrition, Institute of Biomedical Research of Málaga (IBIMA), Regional University Hospital of Málaga, University of Málaga, Málaga, Spain.
Maria Soledad Ruiz de AdanaDiabetes Unit, Department of Endocrinology and Nutrition, Institute of Biomedical Research of Málaga (IBIMA), Regional University Hospital of Málaga, University of Málaga, Málaga, Spain.
María Teresa AnarteDepartment of Personality, Assessment and Psychological Treatment, Institute of Biomedical Research of Malaga (IBIMA), University of Málaga, Málaga, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study focuses on the development and validation of a new Type 1 Diabetes Adjustment Scale (DAS-1).

methodA total of 204 participants aged 15-65 with type 1 diabetes completed the self-report measures of the DAS-1, which includes clinical and psychological variables.

resultsRobust confirmatory factor analysis detected a unidimensional structure of the item scores. The omega coefficient was 0.91 and test-retest reliability was 0.87. Classifying subjects as in a Positive or Negative mood state, ROC analysis yielded an optimal cut-off of 50 for the DAS-1 scores, with a clinical accuracy of AUC = 0.85. The DAS-1 demonstrated evidence of good reliability and acceptable construct validity.

conclusionThe DAS-1 demonstrated good clinical utility, good sensitivity and adequate specificity. Clinical and theoretical implications of these results are discussed.

Indexed as

adjustment scaleassessmentreliabilityrobust factor structuretype 1 diabetesvalidity

Identifiers

PMID32372997
PMCPMC7177012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.